Root Financial Partners
MYGN icon

Root Financial Partners’s Myriad Genetics MYGN Stock Holding History

Root Financial Partners’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$34 Buy
+8
New +$34 ﹤0.01% 3756
2026
Q2 		– Sell
-224
Closed -$1.01K – 2143
2026
Q1 		$1.01K Buy
+224
New +$1.17K ﹤0.01% 2613

Other funds holding MYGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Root Financial Partners's MYGN Position: Q3 2026 in Review

Root Financial Partners opened a new position in Myriad Genetics (MYGN) in Q3 2026: 8 shares worth $34. The stake represents ﹤0.01% of the portfolio and ranks #3756 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in MYGN as recently as Q1 2026.

Root Financial Partners first reported a position in MYGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.01K in Q1 2026. 79 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Root Financial Partners held 8 shares of Myriad Genetics worth $34 as of Q3 2026.
  • Myriad Genetics was a new Root Financial Partners position in Q3 2026.
  • Myriad Genetics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3756 holding.
  • Root Financial Partners first reported a position in Myriad Genetics in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Myriad Genetics position peaked at $1.01K in Q1 2026.
  • 79 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.